Cited by 253Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and LipoproteinsSodium Intake and Health

Overweight and Hypertension: A 2-Way Street?

Open access
Julius, Stevo, Valentini, Mariaconsuelo, Palatini, Paolo·2000·Hypertension

Abstract

Abstract —Cross-sectionally, higher weight is associated with higher blood pressure levels; prospectively, baseline weight and weight gain predict higher blood pressure. The loss of weight is frequently associated with a decrease in blood pressure. These findings suggest that weight gain may pathophysiologically contribute to blood pressure elevation. In this review, we present data to indicate that the reverse is also true; persons of equal weight who had higher initial blood pressures gain more weight in the future. We also propose a plausible hypothesis to explain this reverse relationship. Both the blood pressure elevation and the gain of weight may reflect a primary increase in sympathetic tone. It is well known that in a milieu of increased sympathetic tone, the β-adrenergic responsiveness decreases. Sympathetic overactivity and decreased cardiovascular β-adrenergic responsiveness have been described in hypertension. β-Adrenergic receptors mediate increases in energy expenditure. If these metabolic receptors were downregulated in hypertension, the ability of hypertensive patients to dissipate calories would decrease and they would gain more weight. The possible relationship of decreased β-adrenergic responsiveness to weight in hypertension can be experimentally tested. Such research may contribute to an explanation of why patients with hypertension can rarely lose weight. An understanding of this pathophysiological relationship may open new avenues for therapeutic interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.35.3.807

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment with β-blockers leads to metabolic complications including weight gain.

    “Given that excessive sympathetic activity is common in obesity, β-blockers appear as an obvious pharmacologic therapy to treat the hypertension associated with this condition, but treatment with β-blockers leads to metabolic complications including weight gain (16–18).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 75 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. Rosenbaum M, Leibel RJ, Hirsch J. Obesity. N Engl J Med. 1997;337: 396 -407. (Correction. 1998;338:555.)
  2. Schwartz RS, Jaeger LF, Silberstein S, Veith RC. Sympathetic nervous system activity and the thermic effect of feeding in man. Int J Obes. 1987;11:141-149.
  3. Blaak EE, van Baak MA, Kempen KPG, Saris WHM. Role of ␣-and ␤-adrenoceptors in sympathetically mediated thermogenesis. Am J Physiol. 1993;264:E11-E17.
  4. Julius S. Neurogenic component in borderline hypertension. In: Julius S, Esler MD, eds. The Nervous System in Arterial Hypertension. Springfield, Ill: Charles C Thomas; 1974:301-330.

Cited by

Sorted by citations

Authors
Julius, S., Valentini, M., & Palatini, P.
Affiliations
University of Padua (IT)
Venue
Hypertension
Published
2000-03
Volume
35
Issue
3
Pages
807-813
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2130252918
Cited by
253
References
75
Citations by year
2025: 11 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 4 · 2016: 11 · 2015: 16 · 2014: 16 · 2013: 12 · 2012: 10
FWCI
2.32
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
overweight, weight gain, blood pressure, weight loss, sympathetic nervous system, beta-adrenergic responsiveness, beta-adrenergic receptor down-regulation, energy expenditure
MeSH terms
Adult, Child, Humans, Hypertension, Obesity, Receptors, Adrenergic, Sympathetic Nervous System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review